아일랜드 - 영어 - HPRA (Health Products Regulatory Authority)

accord healthcare limited - topotecan (as hydrochloride) - pdr/conc/soln for infus - 4 milligram

싱가포르 - 영어 - HSA (Health Sciences Authority)

novartis (singapore) pte ltd - topotecan hcl eqv topotecan - injection, powder, for solution - 4 mg/vial - topotecan hcl eqv topotecan 4 mg/vial

오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

fresenius kabi australia pty limited - topotecan hydrochloride -

뉴질랜드 - 영어 - Medsafe (Medicines Safety Authority)

novartis new zealand ltd - topotecan hydrochloride 0.27mg equivalent to 0.25 mg topotecan - capsule - 0.25 mg - active: topotecan hydrochloride 0.27mg equivalent to 0.25 mg topotecan excipient: gelatin glyceryl monostearate hydrogenated vegetable oil tekprint black sw-9008 titanium dioxide - hycamtin capsules are indicated for the treatment of patients with relapsed small cell lung carcinoma (sclc).

뉴질랜드 - 영어 - Medsafe (Medicines Safety Authority)

novartis new zealand ltd - topotecan hydrochloride 1.24mg equivalent to 1.1 mg topotecan free base (incl. 10% overage) - powder for infusion - 1 mg - active: topotecan hydrochloride 1.24mg equivalent to 1.1 mg topotecan free base (incl. 10% overage) excipient: hydrochloric acid mannitol sodium hydroxide tartaric acid - hycamtin powder for infusion is indicated for: · monotherapy for the treatment of patients with: small cell lung carcinoma (sclc) after failure of first line chemotherapy metastatic carcinoma of the ovary after failure of first-line or subsequent therapy · combination therapy with cisplatin for the treatment of patients with histologically confirmed stage iv-b, recurrent, or persistent carcinoma of the cervix, which is not amenable to curative treatment with surgery and/or radiation therapy

캐나다 - 영어 - Health Canada

novartis pharmaceuticals canada inc - topotecan (topotecan hydrochloride) - powder for solution - 4mg - topotecan (topotecan hydrochloride) 4mg - antineoplastic agents

아일랜드 - 영어 - HPRA (Health Products Regulatory Authority)

fresenius kabi oncology plc - topotecan hydrochloride - pdr for soln for infusion - 4 mg/ml - other antineoplastic agents

아일랜드 - 영어 - HPRA (Health Products Regulatory Authority)

pliva pharma limited - topotecan hydrochloride - pdr/conc/soln for infus - 4 milligram

영국 - 영어 - MHRA (Medicines & Healthcare Products Regulatory Agency)

medac uk - topotecan hydrochloride - solution for infusion - 1mg/1ml

영국 - 영어 - MHRA (Medicines & Healthcare Products Regulatory Agency)

medac uk - topotecan hydrochloride - solution for infusion - 1mg/1ml